tiprankstipranks
Terveystalo Oy Class A (TTALF)
OTHER OTC:TTALF
US Market

Terveystalo Oy (TTALF) Earnings Dates, Call Summary & Reports

7 Followers

Earnings Data

Report Date
Jul 17, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
0.17
Last Year’s EPS
0.2
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Apr 24, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call balanced substantial near-term challenges (broad, market-driven demand decline, visit volumes down ~9.6%, revenue and cash flow pressure, and outsourcing/public-sector shrinkage) against strong operational execution (high absolute profitability, NPS 88), tangible digital/efficiency milestones (Ella 30% efficiency gain, live MedHelp platform, AI-assisted appointments), and a healthy balance sheet (net debt/EBITDA 2.4x). Management communicated that the market has likely bottomed out and that they expect gradual improvement into H2 while reiterating full-year guidance though they see risks below the midpoint. Overall, positives are meaningful but many are forward-looking or operational mitigations, while notable demand and cash headwinds remain in the near term.
Company Guidance
Terveystalo reiterated full‑year 2026 adjusted EBIT guidance of EUR 135–165 million (noting their scenarios currently skew below the midpoint), supported by Q1 adjusted EBIT of EUR 34.0 million (reported EBIT EUR 26.6m) despite headwinds: visit growth -9.6%, Healthcare Services volumes down c.11%, connected employees -5%, ~43,000 fewer upper respiratory disease cases, and EPS‑impacting adjustment items of EUR 7m; profitability in H1 is expected to be below H1 2025, Q2 will be weak, Q3 seasonally low and Q4 is where recovery (as URI normalizes in H2) should materialize. Management pointed to operational actions (FTEs adjusted ~10%), a strong NPS of 88, LTM investments of EUR 56m, a net debt/EBITDA of 2.4 and an expected EUR 20m reduction in outsourcing revenues in 2026, while anticipating H2 growth and an Hohde closing likely in Q3.
Operational Profitability in Absolute Terms
Adjusted EBIT of EUR 34.0 million in Q1 and reported EBIT of EUR 26.6 million; management notes this Q1 is among the top three best quarters ever in absolute EBITDA/EBIT despite weak market conditions.
Customer Satisfaction Strong
NPS for appointments at a stellar 88, indicating high customer satisfaction and service quality.
Digital and Platform Rollouts Live with Early Traction
New occupational health digital platform (joint venture with MedHelp) is launched and in use by paying customers; AI-assisted appointments introduced and being scaled.
Clinician Efficiency Gains from Ella
Ella physician user interface is live and delivering approximately a 30% efficiency improvement for physicians where deployed.
Dental / Portfolio Business Performing Relatively Well
Dental business was flat in Q1 and reported as the best-performing discipline in relative terms; Hohde acquisition progressing with constructive dialogue and expected closing more likely in Q3 than Q4.
Active Cost and Resource Adjustments
Operations adjusted to lower demand: patient-facing volumes down ~11% and FTEs reduced by ~10% in Healthcare Services, demonstrating rapid operational responsiveness to the demand drop.
Investment Discipline and Ongoing Capex
LTM investments of EUR 56 million focused on live, in-production initiatives (Ella, MedHelp, digital 10X) that management believes are already positively impacting operations.
Balance Sheet and Leverage Manageable
Net debt / EBITDA at 2.4x; company describes balance sheet as strong and able to continue investing despite Q1 cash headwinds.

Terveystalo Oy (TTALF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TTALF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 17, 2026
2026 (Q2)
0.17 / -
0.197
Apr 24, 2026
2026 (Q1)
0.27 / 0.16
0.314-48.15% (-0.15)
Feb 13, 2026
2025 (Q4)
0.29 / 0.19
0.1746.67% (+0.01)
Oct 23, 2025
2025 (Q3)
0.18 / 0.16
0.1517.69% (+0.01)
Jul 17, 2025
2025 (Q2)
0.24 / 0.20
0.209-5.56% (-0.01)
Apr 25, 2025
2025 (Q1)
0.26 / 0.31
0.22142.11% (+0.09)
Feb 14, 2025
2024 (Q4)
0.25 / 0.17
0.197-11.76% (-0.02)
Oct 25, 2024
2024 (Q3)
0.11 / 0.15
0.067124.14% (+0.08)
Jul 17, 2024
2024 (Q2)
0.16 / 0.21
0.07200.00% (+0.14)
Apr 26, 2024
2024 (Q1)
0.16 / 0.22
0.1822.58% (+0.04)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TTALF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 24, 2026
$11.00$11.000.00%
Feb 13, 2026
$8.65$8.650.00%
Oct 23, 2025
$12.51$12.510.00%
Jul 17, 2025
$12.24$12.240.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Terveystalo Oy Class A (TTALF) report earnings?
Terveystalo Oy Class A (TTALF) is schdueled to report earning on Jul 17, 2026, Before Open (Confirmed).
    What is Terveystalo Oy Class A (TTALF) earnings time?
    Terveystalo Oy Class A (TTALF) earnings time is at Jul 17, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TTALF EPS forecast?
          TTALF EPS forecast for the fiscal quarter 2026 (Q2) is 0.17.